APA

Katsumata K., Tomioka H., Sumi T., Yamashita S., Takagi M., Kato F., Nakamura R., Koyanagi Y., Aoki T. & Kato K. (20030326). Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens. : Cancer chemotherapy and pharmacology.

Chicago

Katsumata Kenji, Tomioka Hidenori, Sumi Tetsuo, Yamashita Shinya, Takagi Makoto, Kato Fumiaki, Nakamura Ryuji, Koyanagi Yasuhisa, Aoki Tatsuya and Kato Kohichiro. 20030326. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens. : Cancer chemotherapy and pharmacology.

Harvard

Katsumata K., Tomioka H., Sumi T., Yamashita S., Takagi M., Kato F., Nakamura R., Koyanagi Y., Aoki T. and Kato K. (20030326). Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens. : Cancer chemotherapy and pharmacology.

MLA

Katsumata Kenji, Tomioka Hidenori, Sumi Tetsuo, Yamashita Shinya, Takagi Makoto, Kato Fumiaki, Nakamura Ryuji, Koyanagi Yasuhisa, Aoki Tatsuya and Kato Kohichiro. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens. : Cancer chemotherapy and pharmacology. 20030326.